Astrocytic aquaporin 4 subcellular translocation as a therapeutic target for cytotoxic edema in ischemic stroke
Open Access
- 1 January 2022
- journal article
- editorial
- Published by Medknow in Neural Regeneration Research
- Vol. 17 (12), 2666-2668
- https://doi.org/10.4103/1673-5374.339481
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid βScience Translational Medicine, 2012
- Loss of astrocyte polarization upon transient focal brain ischemia as a possible mechanism to counteract early edema formationGlia, 2012
- Glial-conditional deletion of aquaporin-4 ( Aqp4 ) reduces blood–brain water uptake and confers barrier function on perivascular astrocyte endfeetProceedings of the National Academy of Sciences of the United States of America, 2011
- Pretreatment with a novel aquaporin 4 inhibitor, TGN-020, significantly reduces ischemic cerebral edemaNeurological Sciences, 2010
- Na+–K+–2Cl− Cotransport Inhibitor Attenuates Cerebral Edema Following Experimental Stroke via the Perivascular Pool of Aquaporin-4Neurocritical Care, 2010
- Inhibition of Aquaporin-1 and Aquaporin-4 Water Permeability by a Derivative of the Loop Diuretic Bumetanide Acting at an Internal Pore-Occluding Binding SiteMolecular Pharmacology, 2009
- Inhibition of Aquaporin 4 by antiepileptic drugsBioorganic & Medicinal Chemistry, 2009
- Antiedema Therapy in Ischemic StrokeStroke, 2007
- Identification of arylsulfonamides as Aquaporin 4 inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral artery occlusion in miceProceedings of the National Academy of Sciences of the United States of America, 2006